Calliditas Therapeutics (CALT)
(Delayed Data from NSDQ)
$19.45 USD
+0.95 (5.14%)
Updated Apr 25, 2024 02:49 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/21/24 |
---|---|
Current Quarter | -0.14 |
EPS Last Quarter | -0.06 |
Last EPS Surprise | 40.00% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.30 |
Next Year | 3.45 |
EPS (TTM) | -1.64 |
P/E (F1) | 65.93 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 35.78M | 40.26M | 185.19M | 342.38M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 38.12M | 41.39M | 190.76M | 443.01M |
Low Estimate | 33.43M | 39.12M | 178.24M | 273.96M |
Year ago Sales | 18.32M | 25.60M | 113.63M | 185.19M |
Year over Year Growth Est. | 95.28% | 57.25% | 62.98% | 84.88% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.14 | -0.05 | 0.30 | 3.45 |
# of Estimates | 2 | 2 | 4 | 3 |
Most Recent Consensus | NA | NA | 0.16 | 1.98 |
High Estimate | -0.08 | 0.04 | 0.82 | 5.42 |
Low Estimate | -0.20 | -0.14 | -0.04 | 1.98 |
Year ago EPS | -0.67 | -0.33 | -1.64 | 0.30 |
Year over Year Growth Est. | 79.10% | 84.85% | 118.29% | 1,052.77% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.14 | -0.05 | 0.30 | 3.45 |
7 Days Ago | -0.14 | -0.05 | 0.30 | 3.45 |
30 Days Ago | -0.14 | -0.05 | 0.30 | 3.45 |
60 Days Ago | -0.14 | -0.05 | 0.30 | 3.45 |
90 Days Ago | -0.06 | 0.16 | 2.58 | 5.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.14 | -0.05 | 0.30 | 3.45 |
Zacks Consensus Estimate | -0.14 | -0.05 | 0.30 | 3.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.06 | -0.58 | -0.33 | -0.67 | NA |
Estimate | -0.10 | -0.22 | -0.25 | -0.57 | NA |
Difference | 0.04 | -0.36 | -0.08 | -0.10 | -0.13 |
Surprise | 40.00% | -163.64% | -32.00% | -17.54% | -43.30% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more